Χώρα: Ιρλανδία
Γλώσσα: Αγγλικά
Πηγή: HPRA (Health Products Regulatory Authority)
Paracetamol; Guaifenesin; Phenylephrine hydrochloride
Wrafton Laboratories Ltd. t/a Perrigo
N02BE; N02BE51
Paracetamol; Guaifenesin; Phenylephrine hydrochloride
500/100/6.1 milligram(s)
Capsule, hard
Product not subject to medical prescription
Anilides; paracetamol, combinations excl. psycholeptics
Marketed
2009-02-20
Package Leaflet: Information for the user Perrigo Cold & Flu Multi-Relief Capsules Paracetamol 500mg, Guaifenesin 100mg, Phenylephrine 6.1 mg READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse. This medicine is available without prescription, however, you still need to use this product carefully to get the best results from it. Keep this leaflet as you may need to read it again. Ask your pharmacist if you need more information or advice. WHAT IS IN THIS LEAFLET: 1. What this medicine is and what it is used for 2. What you need to know before you take this medicine 3. How to take this medicine 4. Possible side effects 5. How to store this medicine 6. Contents of the pack and other information 1) WHAT THIS MEDICINE IS AND WHAT IT IS USED FOR THIS MEDICINE CONTAINS: • PARACETAMOL which is a pain reliever (analgesic) and helps reduce your temperature when you have a fever • GUAIFENESIN which is an expectorant to help loosen phlegm • PHENYLEPHRINE which is a decongestant to reduce swelling in the passages of the nose to help you breathe more easily. These capsules are used for the relief of the symptoms of colds and flu and the pain and congestion of sinusitis, including aches and pains, headache, blocked nose and sore throat, chills and feverishness (high temperature). They can also loosen stubborn mucus (phlegm) and provide relief from chesty coughs. 2) WHAT YOU NEED TO KNOW BEFORE YOU TAKE THIS MEDICINE DO NOT TAKE THIS MEDICINE IF YOU: • HAVE EVER HAD AN ALLERGIC REACTION to paracetamol, guaifen Διαβάστε το πλήρες έγγραφο
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Perrigo Cold & Flu Multi-Relief Capsules Paracetamol 500mg, Guaifenesin 100mg, Phenylephrine 6.1mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredient mg/Capsule Paracetamol 500 Guaifenesin 100 Phenylephrine hydrochloride 6.1 For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Capsule, hard. Dark blue/dark green hard gelatin capsules containing the drug product, an off-white powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief of symptoms associated with colds and flu and the pain and congestion of sinusitis, including aches and pains, headache, blocked nose and sore throat, chills, lowering of temperature, and to loosen stubborn mucous and provide relief from chesty coughs. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of administration: Oral. Take capsules with water. Swallow whole, do not chew. For all indications: Adults, the elderly and children aged 16 years and over: Two capsules every 4-6 hours when necessary to a maximum of 4 doses in 24 hours. Children under 16 years: Do not give to children under 16 years of age. Dosage should not be continued for longer than 3 days without consulting a doctor. 4.3 CONTRAINDICATIONS Hypersensitivity to paracetamol, guaifenesin or phenylephrine or any of the other ingredients. Hepatic or severe renal impairment, hypertension, hyperthyroidism, diabetes, heart disease or those taking tricyclic antidepressants or beta-blocking drugs and those patients who are taking or have taken, within the last two weeks, monoamine oxidase inhibitors (see section 4.5). Phaeochromocytoma. Prostatic enlargement or urinary retention. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ __ Διαβάστε το πλήρες έγγραφο